Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ActVA-Orf6 monooxygenase is a small enzyme (113 amino acids) with a unique ferredoxin-like fold and dimeric assembly, found in Streptomyces coelicolor and other actinobacteria[1][8]. It plays a key role in the biosynthetic pathway leading to actinorhodin, an antibiotic compound, by oxidizing large three-ring aromatic substrates during secondary metabolite production. The enzyme’s active site consists of conserved residues (notably Asn62 and Trp66), and it functions without a metal ion or prosthetic group, distinguishing it from many other monooxygenases. While not a direct therapeutic target, its structural and mechanistic characterization informs biotechnological research in antibiotic development[1][8][5].
Catalyzes monooxygenation reactions on large aromatic intermediates in actinorhodin biosynthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ActVA-Orf6 monooxygenase (ActVA-Orf6).